ABSTRACT
Objective: To elucidate the in vivo hypoglycemic capability, antihyperglycemic and antihyperlipidemic activities of Pereskia bleo (Kunth) leaves extracts and bioactive fraction. Methods: The various solvent extracts of Pereskia bleo were investigated for the hypoglycemic and antihyperglycemic activities using a relevant in vivo normal rat model and streptozotocin-induced diabetic rat model with glibenclamide and metformin utilized as positive controls. The effects of the most potent extract and its bioactive fraction on the insulin level, lipid profile and body weight of the diabetic rats were also analyzed. Results: All the extracts showed no hypoglycemic effect while petroleum ether, chloroform and aqueous extracts demonstrated significant (P<0.05) reduction in blood sugar level in the intraperitoneal glucose tolerance test. Aqueous extract and aqueous fraction significantly (P<0.05) reduced the blood glucose level in streptozotocin-induced diabetic rats as early as day 6 compared to the diabetic control as well as significantly restored the serum insulin of diabetic rats. Moreover, the aqueous extract and aqueous fraction disclosed a significant (P<0.05) reduction in total cholesterol, triglycerides, and low-density lipoprotein levels. An elevation in high-density lipoprotein as well as improved body weight loss of the diabetic rats were also observed. Conclusions: In summary, Pereskia bleo appears effective in the management of diabetes and correlated impairments arising from high blood sugar level. Further studies will possibly bring about the discovery of effective and secure plant derived antidiabetic drugs.
ABSTRACT
Objective: To elucidate the in vivo hypoglycemic capability, antihyperglycemic and antihyperlipidemic activities of Pereskia bleo (Kunth) leaves extracts and bioactive fraction. Methods: The various solvent extracts of Pereskia bleo were investigated for the hypoglycemic and antihyperglycemic activities using a relevant in vivo normal rat model and streptozotocin-induced diabetic rat model with glibenclamide and metformin utilized as positive controls. The effects of the most potent extract and its bioactive fraction on the insulin level, lipid profile and body weight of the diabetic rats were also analyzed. Results: All the extracts showed no hypoglycemic effect while petroleum ether, chloroform and aqueous extracts demonstrated significant (P<0.05) reduction in blood sugar level in the intraperitoneal glucose tolerance test. Aqueous extract and aqueous fraction significantly (P<0.05) reduced the blood glucose level in streptozotocin-induced diabetic rats as early as day 6 compared to the diabetic control as well as significantly restored the serum insulin of diabetic rats. Moreover, the aqueous extract and aqueous fraction disclosed a significant (P<0.05) reduction in total cholesterol, triglycerides, and low-density lipoprotein levels. An elevation in high-density lipoprotein as well as improved body weight loss of the diabetic rats were also observed. Conclusions: In summary, Pereskia bleo appears effective in the management of diabetes and correlated impairments arising from high blood sugar level. Further studies will possibly bring about the discovery of effective and secure plant derived antidiabetic drugs.
ABSTRACT
Aims:The study examines effect of aqueous-fraction of ethanolic extractof Balanites aegyptiacastem-bark on enzymes of glucose metabolism in streptozotocin (STZ)-induced diabetic rats in a bid to ascertain its anti-hyperglycemic and possible mechanism of action.Methodology:Diabetes was induced in male rats by intra-peritoneal injection of 60 mg/kg body weight of STZ. Dried powdered Balanitesaegyptiacastem-bark was defatted with hexane and extracted using ethanol followed by solvent-solvent fractionation with water and ethyl acetate. The aqueous fraction (ASF) obtained was subjected to acute toxicity on wistar rats using a gradient dosage, where 1/10thof lethal dose was calculated and used for the study. It was orally administered at a dose of 400 mg/kg body weight of diabetic rats, metformin (200 mg/kg body wt) serve as reference drug and diabetic/normal untreated rats received 10 % dimethyl sulfurdioxide for the 28 days treatment period. On day 29th, rats were sacrificed; blood and liver samples were collected. Liver tissues were homogenized, centrifuged and the supernatants were used for assay of glucose metabolic enzymes while serum was used for biochemical markers estimations.Results:Results obtained showed no death or lethal effect in the acute toxicity study up to a dose of 4000 mg/kg body wt. Therefore, the LD50value was considered to be more than 4000 mg/kg body wt.Streptozotocin-induced diabetic rats treated with ASF showed a significant (P<0.05) reversal effect in activities of the glucose metabolic enzymes assayed compare to untreated diabetic rats. Glucokinase activity was enhanced (2.98±2.23U/min/mg Protein) against untreated diabetic (2.22±0.02 U/min/mg Protein) as well as glycogen synthase (12.48±0.11x10-2U/min/mg Protein) against untreated diabetic (9.41±0.34x10-2U/min/mg Protein. Glucose-6-phosphatase activity was suppressed in the diabetic rats received ASF (0.26±0.03 U/min/mg Protein) compare to the untreated diabetic (1.44±0.05 U/min/mg Protein). Glycogen content of the treated diabetic ratswas elevated to 13.77±0.32 mg/g liver against the diabetic untreated rats (10.69±0.32 mg/g liver).A significant reduction in fasting blood glucose was recorded from the ASF treated diabetic rats (290.4±18.4mg/dL) compared to diabetic untreated rats (336.0±11.9mg/dL). Conclusion: The study suggested that Balanites aegyptiacastem-bark may contained compound(s) that has the capacity to reverse the activity of glucose metabolic enzymes to exert antihyperglycemic activity.
ABSTRACT
Aims: To investigate the antimicrobial activity of ethyl acetate and residual aqueous fractions of the methanol extract of Alchornea cordifolia leaf against Pseudomonas aeruginosa ATCC 10145, Staphylococcus aureus ATCC 12600, Escherichia coli ATCC 11775 and Candida albicans ATCC 18804 in comparison to standard antibiotics. Study design: Extraction of Alchornea cordifolia leaf, partitioning of the extract, susceptibility tests (Zones of inhibition) and Minimum Inhibitory and Bactericidal Concentrations determination. Place and Duration of Study: Department of Medicinal Plant Research and Department of Pharmaceutical Microbiology and Biotechnology, National Institute for Pharmaceutical Research and Development, Idu – Abuja, Nigeria and Department of Pharmaceutics and Pharmaceutical Microbiology, Ahmadu Bello University, Zaria, Nigeria, July and October. Methodology: The leaves of Alchornea cordifolia (Schum. & Thonn.) Muell. Arg. were collected, dried at room temperature and extracted with methanol using a soxhlet extractor. The methanol extract was partitioned between ethyl acetate and distilled water to obtain an ethyl acetate sub-fraction (EAF) and an aqueous residual fraction (AF). Agar well diffusion and agar dilution methods according to Clinical Laboratory Standards Institute (CLSI) were used to test the antimicrobial activity of the ethyl acetate and aqueous fractions of Alchornea cordifolia against the above mentioned microbial species. Results: Both fractions; ethyl acetate and residual aqueous fractions of the methanol extract showed antimicrobial activity against the standard organisms viz: Pseudomonas aeruginosa ATCC 10145, Staphylococcus aureus ATCC 12600, Escherichia coli ATCC 11775 and Candida albicans ATCC 18804. The highest activity was observed for the ethyl acetate fraction against Staphylococcus aureus ATCC 12600 with zone of inhibition of 27 mm, Minimum Inhibitory Concentration (M.I.C) of 1.25 mg/ml and Minimum Bactericidal Concentration (M. B. C) of 2.5mg/ml. Conclusion: Pseudomonas aeruginosa ATCC 10145, Staphylococcus aureus ATCC 12600, Escherichia coli ATCC 11775 and Candida albicans ATCC 18804 were susceptible to the ethyl acetate sub-fraction and residual aqueous fractions of the methanol extract of Alchornea cordifolia leaf.